Suppr超能文献

帕金森病的代偿机制:神经回路适应性及其在疾病修饰中的作用。

Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

作者信息

Blesa Javier, Trigo-Damas Inés, Dileone Michele, Del Rey Natalia Lopez-Gonzalez, Hernandez Ledia F, Obeso José A

机构信息

HM CINAC, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain; Biomedical Research Center of Neurodegenerative Diseases (CIBERNED), Instituto Carlos III, Madrid, Spain.

HM CINAC, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain; Biomedical Research Center of Neurodegenerative Diseases (CIBERNED), Instituto Carlos III, Madrid, Spain.

出版信息

Exp Neurol. 2017 Dec;298(Pt B):148-161. doi: 10.1016/j.expneurol.2017.10.002. Epub 2017 Oct 4.

Abstract

The motor features of Parkinson's disease (PD) are well known to manifest only when striatal dopaminergic deficit reaches 60-70%. Thus, PD has a long pre-symptomatic and pre-motor evolution during which compensatory mechanisms take place to delay the clinical onset of disabling manifestations. Classic compensatory mechanisms have been attributed to changes and adjustments in the nigro-striatal system, such as increased neuronal activity in the substantia nigra pars compacta and enhanced dopamine synthesis and release in the striatum. However, it is not so clear currently that such changes occur early enough to account for the pre-symptomatic period. Other possible mechanisms relate to changes in basal ganglia and motor cortical circuits including the cerebellum. However, data from early PD patients are difficult to obtain as most studies have been carried out once the diagnosis and treatments have been established. Likewise, putative compensatory mechanisms taking place throughout disease evolution are nearly impossible to distinguish by themselves. Here, we review the evidence for the role of the best known and other possible compensatory mechanisms in PD. We also discuss the possibility that, although beneficial in practical terms, compensation could also play a deleterious role in disease progression.

摘要

帕金森病(PD)的运动特征众所周知,只有当纹状体多巴胺能缺陷达到60 - 70%时才会显现。因此,PD有很长的症状前期和运动前期演变过程,在此期间会发生代偿机制以延迟致残表现的临床发作。经典的代偿机制归因于黑质 - 纹状体系统的变化和调整,如黑质致密部神经元活动增加以及纹状体中多巴胺合成和释放增强。然而,目前尚不清楚这些变化是否足够早地发生以解释症状前期。其他可能的机制与包括小脑在内的基底神经节和运动皮质回路的变化有关。然而,早期PD患者的数据很难获得,因为大多数研究都是在确诊和开始治疗后进行的。同样,在整个疾病演变过程中发生的假定代偿机制几乎无法单独区分。在此,我们回顾了最知名的和其他可能的代偿机制在PD中作用的证据。我们还讨论了这样一种可能性,即尽管从实际角度来看代偿是有益的,但它也可能在疾病进展中起有害作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验